Indo Amines Limited
Indo Amines Limited Fundamental Analysis
Indo Amines Limited (INDOAMIN.NS) shows moderate financial fundamentals with a PE ratio of 11.12, profit margin of 6.27%, and ROE of 21.95%. The company generates $11.3B in annual revenue with weak year-over-year growth of -0.15%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 42.4/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze INDOAMIN.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakINDOAMIN.NS struggles to generate sufficient returns from assets.
Valuation Score
ModerateINDOAMIN.NS shows balanced valuation metrics.
Growth Score
WeakINDOAMIN.NS faces weak or negative growth trends.
Financial Health Score
ExcellentINDOAMIN.NS maintains a strong and stable balance sheet.
Profitability Score
WeakINDOAMIN.NS struggles to sustain strong margins.
Key Financial Metrics
Is INDOAMIN.NS Expensive or Cheap?
P/E Ratio
INDOAMIN.NS trades at 11.12 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, INDOAMIN.NS's PEG of 9.66 indicates potential overvaluation.
Price to Book
The market values Indo Amines Limited at 2.18 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 3.67 times EBITDA. This is generally considered low.
How Well Does INDOAMIN.NS Make Money?
Net Profit Margin
For every $100 in sales, Indo Amines Limited keeps $6.27 as profit after all expenses.
Operating Margin
Core operations generate 8.29 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $21.95 in profit for every $100 of shareholder equity.
ROA
Indo Amines Limited generates $8.38 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Indo Amines Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Indo Amines Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
INDOAMIN.NS converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
11.12
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
9.66
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.18
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.70
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.85
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.27
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.22
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.21
vs 25 benchmark
How INDOAMIN.NS Stacks Against Its Sector Peers
| Metric | INDOAMIN.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 11.12 | 27.21 | Better (Cheaper) |
| ROE | 21.95% | 861.00% | Weak |
| Net Margin | 6.27% | -120574.00% (disorted) | Weak |
| Debt/Equity | 0.85 | 0.41 | Weak (High Leverage) |
| Current Ratio | 1.27 | 4.82 | Neutral |
| ROA | 8.38% | -7642.00% (disorted) | Weak |
INDOAMIN.NS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Indo Amines Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
81.45%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
70.46%
Industry Style: Cyclical, Commodity, Value
High GrowthFCF CAGR
154.90%
Industry Style: Cyclical, Commodity, Value
High Growth